Ira Scott Greenspan - 31 Jul 2021 Form 4 Insider Report for Scopus BioPharma Inc.

Role
Executive Committee Chairman, Director, 10%+ Owner
Signature
/s/ Ira Scott Greenspan
Issuer symbol
SCPS on OTC
Transactions as of
31 Jul 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 18:50:07 UTC
Previous filing
27 Jul 2021
Next filing
19 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPS W Warrants Other +1,068,016 1,068,016 31 Jul 2021 B Unit 1,068,016 $4.00 SCPS/Strategic Capital Partners LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Greenspan is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Greenspan disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein.
F2 Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.